363 related articles for article (PubMed ID: 28550479)
21. Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder.
Kumar A; Agarwal S; Agarwal D; Phadke SR
Gene; 2013 Jun; 522(2):226-30. PubMed ID: 23570879
[TBL] [Abstract][Full Text] [Related]
22. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
[TBL] [Abstract][Full Text] [Related]
23. Myotonic dystrophy type 2 and related myotonic disorders.
Meola G; Moxley RT
J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094
[TBL] [Abstract][Full Text] [Related]
24. Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2.
Wenninger S; Stahl K; Montagnese F; Schoser B
Eur Neurol; 2020; 83(5):523-533. PubMed ID: 33120389
[TBL] [Abstract][Full Text] [Related]
25. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
26. Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2.
Montagnese F; Mondello S; Wenninger S; Kress W; Schoser B
J Neurol; 2017 Dec; 264(12):2472-2480. PubMed ID: 29086017
[TBL] [Abstract][Full Text] [Related]
27. Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism.
Meola G; Cardani R
J Neuromuscul Dis; 2015 Jul; 2(s2):S59-S71. PubMed ID: 27858759
[TBL] [Abstract][Full Text] [Related]
28. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.
Suominen T; Bachinski LL; Auvinen S; Hackman P; Baggerly KA; Angelini C; Peltonen L; Krahe R; Udd B
Eur J Hum Genet; 2011 Jul; 19(7):776-82. PubMed ID: 21364698
[TBL] [Abstract][Full Text] [Related]
29. Dysautonomia as Onset Symptom of Myotonic Dystrophy Type 2.
Rossi S; Romano A; Modoni A; Perna F; Rizzo V; Santoro M; Monforte M; Pieroni M; Luigetti M; Pomponi MG; Silvestri G
Eur Neurol; 2018; 79(3-4):166-170. PubMed ID: 29533949
[TBL] [Abstract][Full Text] [Related]
30. Myotonic Muscular Dystrophies.
Johnson NE
Continuum (Minneap Minn); 2019 Dec; 25(6):1682-1695. PubMed ID: 31794466
[TBL] [Abstract][Full Text] [Related]
31. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
[TBL] [Abstract][Full Text] [Related]
32. Towards clinical outcome measures in myotonic dystrophy type 2: a systematic review.
Rastelli E; Montagnese F; Massa R; Schoser B
Curr Opin Neurol; 2018 Oct; 31(5):599-609. PubMed ID: 30048337
[TBL] [Abstract][Full Text] [Related]
33. The myotonic dystrophies: molecular, clinical, and therapeutic challenges.
Udd B; Krahe R
Lancet Neurol; 2012 Oct; 11(10):891-905. PubMed ID: 22995693
[TBL] [Abstract][Full Text] [Related]
34. [Myotonic dystrophy].
Nanba E
Nihon Rinsho; 2005 Mar; 63(3):429-33. PubMed ID: 15773341
[TBL] [Abstract][Full Text] [Related]
35. Myotonic dystrophy type 2 found in two of sixty-three persons diagnosed as having fibromyalgia.
Auvinen S; Suominen T; Hannonen P; Bachinski LL; Krahe R; Udd B
Arthritis Rheum; 2008 Nov; 58(11):3627-31. PubMed ID: 18975316
[TBL] [Abstract][Full Text] [Related]
36. Cerebral involvement in myotonic dystrophies.
Meola G; Sansone V
Muscle Nerve; 2007 Sep; 36(3):294-306. PubMed ID: 17486579
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic variability and molecular genetics in proximal myotonic myopathy.
Papadimas GK; Kekou K; Papadopoulos C; Kararizou E; Kanavakis E; Manta P
Muscle Nerve; 2015 May; 51(5):686-91. PubMed ID: 25186227
[TBL] [Abstract][Full Text] [Related]
38. Myotonic dystrophies.
Huang CC; Kuo HC
Chang Gung Med J; 2005 Aug; 28(8):517-26. PubMed ID: 16265841
[TBL] [Abstract][Full Text] [Related]
39. Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2.
Cardani R; Giagnacovo M; Rossi G; Renna LV; Bugiardini E; Pizzamiglio C; Botta A; Meola G
Neuromuscul Disord; 2014 Dec; 24(12):1042-53. PubMed ID: 25139674
[TBL] [Abstract][Full Text] [Related]
40. New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2).
Sallinen R; Vihola A; Bachinski LL; Huoponen K; Haapasalo H; Hackman P; Zhang S; Sirito M; Kalimo H; Meola G; Horelli-Kuitunen N; Wessman M; Krahe R; Udd B
Neuromuscul Disord; 2004 Apr; 14(4):274-83. PubMed ID: 15019706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
